Close

Nxstage Medical (NXTM) Tops Q3 EPS by 4c

November 3, 2016 8:07 AM EDT

Nxstage Medical (NASDAQ: NXTM) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $92 million versus the consensus estimate of $89.82 million.

GUIDANCE:

Nxstage Medical sees FY2016 revenue of $360-365 million.

For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings